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Objective: This study was undertaken to illustrate the safety of in situ reconstruction of septic aortic pseudoaneurysm
(SAP) secondary to microbial aortitis, with or without long-term antibiotic treatment.
Methods: Data for patients with SAP (11 abdominal, 4 thoracic) operated on between 1993 and 1999 were reviewed.
Computed tomography and aortography showed septic pseudoaneurysm in all patients before surgery. After diagnosis of
SAP, all patients underwent aneurysm resection and extensive debridement, with in situ prosthetic grafting or patch
repair angioplasty. The graft in 10 of the 11 patients with abdominal SAP was also wrapped with an omental pedicle. In
vitro active parenteral antibiotic therapy was prescribed for all patients for at least 2 to 8 weeks after surgery.
Results: All 15 patients had positive preoperative blood cultures or intraoperative tissue cultures for Salmonella spp (n 
12), viridans Streptococcus (n  1), group G Streptococcus (n  1), or Streptococcus pneumoniae (n  1). There were two
perioperative deaths (13.3%), one 6 days after surgery and the other 19 days after surgery, and two late deaths, at 8 and
10 months after surgery, neither of which was related to aortic repair. One patient was unavailable for follow-up. The
other 10 patients have been regularly followed up with abdominal ultrasound or computed tomography (mean, 84
months; range, 47-118 months). To date, there has been no graft infection, thrombosis, false aneurysm, or subsequent
aortic surgery in these 10 patients.
Conclusion: SAP due to Salmonella and streptococcal microbial arortitis can be successfully treated with resection of the
aneurysm and extensive debridement, followed by in situ prosthetic graft interposition or patch repair aortoplasty. This
is a safe and effective treatment that may result in complete remission of SAP. Postoperative parenteral antibiotic therapy
should be continued for 2 to 8 weeks. Although usually recommended, lifelong suppressive antibiotic therapy appears to
be nonessential with this approach. (J Vasc Surg 2003;38:975-82.)
The term “mycotic aneurysm” was first used in 1885 by
Sir William Osler1 because of the beaded and multilobu-
lated appearance of the aneurysm formation occurring in
“malignant endocarditis.” Most authors use it in a broader
sense to describe any kind of infected aneurysm, regardless
of its pathogenesis. In this report, however, septic aortic
pseudoaneurysm (SAP) is used to describe aortic pseudo-
aneurysm caused by bacterial invasion of the vessel wall,
with or without bacteremia.2 There are three criteria for
inclusion: positive signs of infection; a documented pseu-
doaneurysm; and either a positive blood culture or positive
tissue culture, or both.
Aortic infection is still highly lethal, and surgical treat-
ment of SAP remains challenging.3 A literature review4-12
of surgical treatment of SAP can be confusing. Whether a
patient should undergo extra-anatomic bypass grafting or
in situ reconstruction with prosthetic graft or allograft is
not well established and remains controversial, as does the
required duration of postoperative antibiotic therapy. The
purposes of this study were to review the clinical course in
15 patients who underwent surgical treatment of SAP
secondary to microbial aortitis during 1993 to 1999, and to
examine the safety of in situ reconstruction with or without
long-term antibiotic therapy.
PATIENTS AND METHODS
Between 1993 and 1999, 113 patients underwent sur-
gery in our hospital to treat aortic aneurysm disease. We
excluded two patients with fusiform aneurysm, not pseu-
doaneurysm; one patient with pseudoaneurysm without
positive signs of infection; and one patient with pseudoan-
eurysm without a positive blood or tissue culture. SAP was
diagnosed in 15 patients (13.3%; 10 men, 5 women; age
range, 53-77 years). Eleven patients had abdominal SAP
(group 1, patients 1-11), and four patients had thoracic
SAP (group 2, patients 12-15) (Table I). All had a medi-
cally documented febrile illness. Eleven patients (73.3%)
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had preoperative abdominal, lower back, or chest pain. Ten
patients (66.7%) had positive preoperative blood cultures,
including Salmonella bacteremia in eight patients and
Streptococcus bacteremia in two patients. Bacterial cultures
of the specimens obtained during surgery, however, yielded
Salmonella spp in 10 patients and Streptococcus in 2 pa-
tients. Surgical specimens from three of these patients
exhibited bacterial colonies. More than half of the patients
(56%, 8 of 15) had diabetes mellitus–associated disease. All
patients underwent emergency aortic computed tomogra-
phy (CT) and aortography before surgery. After the diag-
nosis and appropriate antibiotic therapy, these patients
were scheduled for surgery as soon as possible for early
control of infection and reduction of risk for aneurysm
rupture.
Resection of SAP, with aggressive and extensive de-
bridement, was performed in each patient. Aortic continu-
ity was reconstructed with an in situ graft or patch repair
angioplasty (until and including 1996, Hemashield; Mea-
dox Medicals, Oakland, NJ; 1996 and after, Hemashield
Gold; Boston Scientific Medi-Tech, Wayne, NJ). In 10 of
11 patients in group 1, the in situ prosthetic graft was also
protected with a great omentum pedicle. There are at least
two techniques for using the omentum pedicle for graft
protection: covering the graft with the pedicle11,13,14 and
completely wrapping the graft in the pedicle.15 We
wrapped the prosthesis completely with the omentum pedi-
cle through the antecolic or retrocolic route, then stapled it
to the surface of the periaortic tissue. The choice of route is
at the discretion of the surgeon. From our experience, if the
prosthesis or the proximal anastomosis is located in a higher
position, such as the suprarenal abdominal aorta, the retro-
colic route seems reasonable; on the contrary, the antecolic
route is suitable with a prosthesis in a lower position. The
pseudoaneurysm in patient 5 was located close to the
diaphragm, too high for the somewhat atrophic and short
omentum to reach the graft; therefore in this patient the
graft was not wrapped in an omentum pedicle. In another
patient there was also patch necrosis of the fourth portion
of the duodenum where it attached to the SAP, which
necessitated wedge resection with primary repair. For the
omentum wrapping procedure we used a retrocolic ap-
proach in three patients and an antecolic route in the rest of
the patients in group 1 (Table II). Two patients each with
an aneurysm located on the distal arch underwent cardio-
pulmonary bypass surgery with deep hypothermia and cir-
culatory arrest to excise the SAP and repair the defect with
patch aortoplasty. The left subclavian artery in one of these
patients was also sutured without blood flow restoration.
Two patients were supported with a femorofemoral bypass
to excise the SAP and reconstruct the artery with an in situ
graft or patch angioplasty (Table II). Each of these patients
underwent simultaneous left upper lobectomy, because the
left upper lobes had been invaded by the aneurysm. Cul-
Table I. Preoperative clinical and bacteriologic data
Patient
no. Sex Age (y) Signs and symptoms
Associated
disease Bacterial species isolated Source of culture
Group 1
1 F 64 Fever, abdominal pain,
pulsatile mass
DM, H/T Salmonella choleraesuis Blood, aneurysm wall
2 F 71 Fever, abdominal pain, septic
shock
DM Salmonella enteritidis, group B Aneurysm wall,
purulent pus
3 M 69 Fever, abdominal pain, septic
shock
CAD Salmonella enteritidis, group B Blood, aneurysm wall,
periaortic pus
4 F 75 Fever, abdominal pain,
pulsatile mass
DM, H/T Salmonella enteritidis, group B Blood





6 M 71 Fever, abdominal pain H/T viridans Streptococcus Aneurysm wall
7 M 65 Fever, abdominal pain H/T S choleraesuis Blood, aneurysm wall,
periaortic pus
8 M 53 Fever Salmonella enteritidis, group C Blood, aneurysm wall
9 M 70 Fever, abdominal pain CAD, DM Salmonella enteritidis, group B Aneurysm wall,
purulent pus
10 M 60 Fever, shock (ruptured
aneurysm)
DM Salmonella enteritidis, group B Blood, aneurysm wall,
purulent pus
11 M 77 Fever, septic shock H/T Salmonella enteritidis, group B Blood
Group 2
12 M 67 Fever, hemoptysis, hoarseness Salmonella choleraesuis aneurysm wall
13 F 59 Fever, chest pain, hoarseness DM, H/T group G Streptococcus Blood, urine,
aneurysm wall,
periaortic pus
14 F 71 Fever, hemothorax, shock
(ruptured aneurysm)
DM Salmonella enteritidis, group B Blood, aneurysm wall,
purulent pus
15 M 75 Fever, hemoptysis DM, CAD Salmonella choleraesuis Aneurysm wall
CAD, Coronary artery disease; DM, diabetes mellitus; H/T, hypertension.
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tures from the aneurysm wall and periaortic infected tissues
or purulent materials were obtained from all patients dur-
ing surgery.
Regular follow-up was carried out in eight patients over
the long term (1 year). During the first year these patients
were seen monthly for the first 3 months and at 3-month
intervals for the next 9 months. Subsequently they were
followed up once a year for 6 years. Imaging studies were
obtained once or twice, at 6 months or 12 months. One
patient was lost to follow-up immediately after surgery.
Another two patients lived far from our hospital and there-
fore sometimes visited other hospitals. All patients were
urged to return to our clinic if they were febrile and had
abdominal or chest pain.
RESULTS
Overview. SAP was located at the distal aortic arch in
2 patients, descending thoracic aorta in 2 patients, supra-
renal abdominal aorta in 2 patients, infrarenal abdominal
aorta in 7 patients, and terminal aorta in 2 patients (Fig 1,
online only). One patient had two aneurysms, one at the
terminal aorta and the other one at the left common iliac
artery. A preoperative contrast medium–enhanced aortic
CT scan showed an irregular aortic lumen and characteristic
hypodense periaortic masses, with ring enhancement be-
yond the intimal calcification. The patients who underwent
preoperative aortography demonstrated typical saccular or
lobular eccentric aneurysms. All patients underwent sur-
gery 0 to 21 days after diagnosis. Two patients were reluc-
tant to have surgery, and their operations were considerably
delayed. During surgery most SAP were found to arise from
the anterior or lateral aspect of the aorta. Induration,
thickening, and inflammation of the wall of the pseudoan-
eurysm were noted. In most patients, microscopic exami-
nation of the resected specimens revealed fibrosis and ath-
eromatous plaque composed of foamy, multinucleated
giant cells and cholesterol crystals, with acute and chronic
inflammatory cell infiltration, and sometimes a bacterial
colony in the aortic wall.
Early results. Two patients died after surgery. In one
of these patients, duodenal leakage developed the day after
surgery, and the patient died 19 days later of uncontrolled
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sepsis and severe gastroduodenal bleeding. Wide and seg-
mental resection of the fourth portion of the duodenum
should have been performed in this patient. The second
patient, with a preoperative ruptured aneurysm and hem-
orrhagic shock, had graft anastomosis leakage the day after
surgery and was returned to the operating room for another
graft replacement because of inadequate debridement of
infected aortic tissue. Paraplegia and acute renal failure
developed after the secondary intervention, and the patient
died 6 days later of multiple organ failure. Seven (53.8%) of
13 surviving patients had one or more non-prosthesis-
related complications (Table I). A duodenal obstruction
due to an adhesion band crossing over the portion just
below the duodenojejunal junction complicated recovery
in one patient and required enterolysis. In one patient with
septic aortoiliac pseudoaneurysm (Fig 2, A, online only)
that had invaded the lumbar vertebrae body (Fig 2, B,
online only), a Salmonella-associated epidural abscess at
L3/5 (Fig 2, C, online only) developed 1 month after the
initial operation, and wide debridement and drainage were
required. This patient was given long-term oral antibiotic
therapy for 4 months. Because an active infected field with
fulminate pus was found during surgery in patient 10,
aggressive and wide debridement was performed. Bilateral
lower leg edema and groin lymph leakage occurred after the
operation, but subsided progressively after conservative
treatment. One patient sustained upper gastroduodenal
bleeding, pneumonia, and bacteremia (oxacillin-resistant
Staphylococcus aureus) via the central venous pressure cath-
eter 1 week after excision of a suprarenal SAP. An additional
2-month regimen of parenteral antibiotic therapy was ad-
ministered for persistent bacteremia, and the patient was
discharged after 4 months of hospitalization. One patient
with a septic aortic arch pseudoaneurysm, who underwent
deep hypothermia and circulatory arrest during aneurysm
excision and patch aortoplasty, had an early postoperative
seizure and consciousness disturbance complications, but
recovered without neurologic sequelae. A patient with
Streptococcus bacteremia via a urinary tract infection also
had intermittent chest pain and hoarseness before admis-
sion. An enhanced chest CT scan demonstrated a distal arch
pseudoaneurysm encircled by a periaortic soft tissue mass
(Fig 3, A). Aortography also proved a distal aortic arch
aneurysm (Fig 3, B). After extensive aneurysmectomy and
patch aortoplasty, the patient was discharged on comple-
tion of a full 4-week course of parenteral antibiotic therapy.
Late results. No recurrent graft infection developed
in any surviving patients during mean follow-up of 84
months (Tables II and III). Eight patients received 2-week
to 9-month oral antibiotic regimens (Table III), but most
chose to terminate the medication early. Four patients were
not given any oral antibiotic therapy. One patient was
unavailable for follow-up 1 month after surgery. There
were two late deaths: one at 10 months, due to brain stem
hemorrhage, and one at 8 months, due to intractable heart
failure. Neither patient had demonstrated signs of graft
infection.
DISCUSSION
SAP is a potentially life-threatening aortic lesion. It is
uncommon, but not rare, and an increasing incidence has
been reported in recent years.5,7,9,16 Compared with the
0.85% incidence (1 of 117 patients) reported by Chan et
al,9 our 13.3% incidence seems higher than series reported
in the West. Moreover, we have the highest incidence of
Salmonella aortitis (80%, 12 of 15 patients) in patients with
SAP published in the English literature.5,7-9,11,12,17-19
There are two important reasons for this. First, people in
the rural agricultural regions of southern Taiwan generally
do not go to supermarkets, which hygienically process,
package, and sell raw meat and fish. Rather, a great many
people in southern Taiwan go to traditional markets, where
all kinds of raw meat or fish are mixed and sold under
hygienically questionable conditions. Salmonella infection
develops easily in these consumers. Second, despite the
1984 revelation by Brown et al3 that the bacteriology of
infected aneurysms had changed pattern, Salmonella or-
ganisms were found in only 10% after 1965. In recent
reports5,7,8,11,19-22 of infected aortitis, however, the inci-
dence of Salmonella infection varies from 18% to 74%. In
our subtropical area, Salmonellosis is still common, with
sporadic outbreaks. A similarly large group of patients with
Salmonella aortitis in this area was reported in 1996,13 but
the incidence of SAP was not documented.
Because the signs and symptoms of SAP are often
elusive and nonspecific, a high index of suspicion is re-
quired to establish the diagnosis. Any patient with pro-
longed fever of unknown origin, with or without recurrent
bacteremia, accompanied by abdominal, back, or chest
pain, should be evaluated for a possible arterial infection
source. Ten of our 15 patients (67%) had prolonged fever
of unknown origin with bacteremia during the first few days
of admission and diagnostic examination. The diagnosis of
SAP was made after CT and aortography. CT is the most
sensitive and useful tool for early detection of the signs of
aortic infection5,23 and should be the first imaging study
done. Although rare—and seen in only one patient in our
series—air in the aortic wall appears to be pathognomonic
of an infected aorta. If the aortic pseudoaneurysm is well
demonstrated on a CT scan, aortography should be per-
formed to confirm the diagnosis and assist in planning the
proper surgical procedure. Aortography often reveals a
characteristic saccular or lobulated eccentric aneurysm.
A combination of aneurysm resection and administra-
tion of in vitro active preoperative and postoperative anti-
biotic therapy is mandatory for effective treatment of SAP.
Successful surgical management of bacterially infected
aortic aneurysms consists of wide and extensive debride-
ment of infected tissue and restoration of distal perfu-
sion. However, some insist that extra-anatomic vascular
bypass grafting is optimal,4,5 whereas others believe an in
situ prosthetic graft or allograft is preferable.9-11,13,24
Conventionally, the extra-anatomic route is recom-
mended to avert placing a prosthetic graft in a contami-
nated region, because of the great risk for graft infection.
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Fig 3. A, Preoperative chest CT scan reveals aortic arch pseudoaneurysm beyond the intimal calcification (arrowhead)
within a large periaortic mass with ring enhancement (arrow). The tissue culture disclosed Streptococcus group G
organisms. B, Preoperative angiogram of patient with Streptococcus bacteremia shows distal aortic arch pseudoaneurysm
(arrowhead).
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This approach has the disadvantage of a reduced graft
patency rate and acute rupture of the aortic stump. It is
also technically difficult when the SAP is located close to
the heart or to the origins of the great visceral vessels. A
1989 review by Oz et al5 of 24 patients treated with
extra-anatomic bypass grafting shows that 11 patients
(46%) died of disease-related complications. This unac-
ceptably high mortality is attributable to the surgical
method selected. Instead of the multiple operations
required for extra-anatomic reconstruction to restore
natural blood flow, in situ grafting offers a definitive
solution in a single operation. The question of whether it
is safe to perform such a procedure in an infected field
may arise. Excellent long-term results after prosthetic
graft or allograft replacement for management of infec-
tions have been reported.9,24-27 Chan et al9 reported
that only 1 of 19 patients had recurrent infection after
follow-up of 3 months to 8 years combined with life-
long suppressive antibiotic therapy. In our series, long-
term suppressive antibiotic therapy was not necessary,
because of our surgical approach.
In one report16 of in situ allograft replacement for
infrarenal infected aortic aneurysm in 43 patients, 5 pa-
tients (12%) died after surgery, and the rate of recurrent
infection was 2.3% with mean follow-up of 13.8 months.
Other preliminary results are also encouraging,24,27-29 es-
pecially those that claim no need for long-term or lifelong
oral antibiotic therapy after 4 to 6 weeks of parenteral
Table III. Postoperative clinical features and outcomes
Patient
no. Complication Outcome

















4.0 — — 107.0
2 Duodenal
leakage




2.5 — — —
3 None Alive Cefmetazole 1.0 g q6h 4.0 Ciprofloxacin 250 mg bid 4.0 101.0
4 None Alive Ampicillin-sulbactam 750
mg q6h
4.0 — — 107.0
5 None Alive Cefotaxime 2.0 g q6h,
2.0 wk
4.0 — — Lost to
follow-up
Vancomycin 500 mg q6h,
2.0 more wk
6 None Alive Penicillin G 300 million
units q6h
4.0 — — 85.0
7 None Alive Ampicillin 2.0 g q6h 2.0 Ciprofloxacin 250 mg bid 0.5 84.0





Alive Ciprofloxacin 400 mg
q12h; 4.0 wk for
infected aneurysm, 4.0
more wk for epidural
abscess












q12h; 4.0 wk for
salmonellosis





Teicoplanin 400 mg qd;
8.0 more wk for
pneumonia
Group 2
12 Seizure Alive Ampicillin 1.0 g q6h;
2.0 wk; Ceftriaxone
2.0 g qd; 4.0 more wk
6.0 Ofloxacin 200 mg bid 9.0 118.0
13 Hoarseness Alive Penicillin G 300 million
units q6h
4.0 Cefadroxil 500 mg bid 8.0 80.0
14 Bleeding,
paraplegia
Died at 6 d
postsurgery






Cefotaxime 2.0 g q6h 4.0 Ciprofloxacin 500 mg bid 2.0 8.0
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antibiotic therapy.27 Although an allograft may offer
greater resistance to infection and allow another in situ
treatment option for infected aortic aneurysm,16,24,27-29
the choice of method for preserving the allograft and
preventing secondary and late deterioration of arterial allo-
grafts remains a major concern. It will require longer fol-
low-up and make close surveillance of these allografts an
obvious necessity. Moreover, organ donation has been a
social issue in Taiwan, and donor sources will be another
concern for in situ allograft reconstruction here.
Oz et al5 reported that diffuse sepsis, large retroperito-
neal hematoma, or large atherosclerotic aneurysm with
superinfection dictates extra-anatomic bypass grafting after
debridement. Other reports10,11,30 agree when extremely
diffuse sepsis with a collection of pus is seen on CT scans or
when osteomyelitis is involved. We, however, think that
none of these conditions necessarily contraindicate in situ
grafting. Adequate and extensive debridement is crucial in
treating SAP. In our series, during surgery frank pus was
seen in seven patients, all of whom had positive cultures for
Salmonella spp or Streptococcus, and four patients even had
extensive purulent pus formations in the periaortic tissue or
advanced infection in the vertebral body. Of the latter four
patients, two survived without late graft infection after the
infected aortic wall and periaortic tissue were extensively
excised. However, the other two patients died in the early
postoperative period as a result of inadequate debridement,
one of duodenal leakage on the second day after surgery
and the other of anastomosis leakage when sutures were
placed in the infected aorta. Although this kind of extensive
debridement may cause some unavoidable complications,
they seem minor in comparison with the high mortality
when surgery is inadequate.
Our initial plan was to give parenteral antibiotics for 4
weeks, followed by oral antibiotic therapy for the rest of the
patient’s life, as suggested by some authors. However, only
eight of our surviving patients received an additional 2
weeks to 9 months of oral antibiotic therapy, and the rest
received only 4 weeks of parenteral antibiotic therapy (Ta-
ble III). All surviving patients seemed to do well, with no
recurrence of graft or other infection after mean follow-up
of 84 months. We believe that debridement of infected
tissue was crucial during surgery to resect infected abdom-
inal SAP; however, omentum pedicle wrapping of the graft
probably also had an important role in the prevention of
abdominal graft infection. One patient had postoperative
lumbar osteomyelitis. Despite this, there was no graft in-
fection because, we suspect, the omentum wrapping pro-
vided protection against it. Although an adhesion ileus
developed in one patient in whom the retrocolic route was
used, it is difficult to definitely attribute this complication
to choice of route.
In group 2, lesions confined to the thoracic aorta in
three patients were reconstructed with simple patch repair
angioplasty after adequate debridement. There was no re-
current sepsis despite no lifelong maintenance antibiotic
therapy. Patch angioplasty for aortic continuity is a simple
procedure and requires less bypass time.
In conclusion, septic abdominal or thoracic aortic pseu-
doaneurysm should be suspected in patients with pro-
longed fever of unknown origin, with or without bactere-
mia and abdominal pain; with fever of unknown origin with
or without a pulsatile abdominal mass; or with fever and
chest pain plus hemoptysis or hoarseness. CT is a rapid
diagnostic tool, and aortography is helpful in surgical plan-
ning. In our series, in situ graft or patch repair angioplasty
after extensive debridement seemed to be safe and effective
when Salmonella or Streptococcus was cultured, even with-
out long-term antibiotic therapy. Ten of 14 patients (71%),
or 10 of 15 patients (68%) if we include the patient lost to
follow-up, remained well and without graft infection at a
mean of 84 months after surgery. Although we might
speculate that in situ reconstruction is worthwhile for other
infections, our data support recommending its use only in
cases in which Salmonella and Streptococcus are cultured.
Also, despite our small population size, the low early mor-
tality rate of 13.3% compares favorably with the best results
of recent series in which in situ reconstruction was
used,9,10,12,16,17 and the high long-term survival rate with-
out maintenance oral antibiotic therapy is quite encourag-
ing. Regular follow-up is mandatory, because sepsis recur-
rence is still a potential problem.
We thank Prof Ray C-J Chiu, Department of Cardio-
vascular and Thoracic Surgery, McGill University, for his
critical review and Bill Franke for proofreading the manu-
script and editing our English.
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Fig 1, online only. The demographic distribution of septic aortic
pseudoaneurysms. *Left common iliac infected aneurysms coinci-
dentally existed with one septic terminal abdominal aortic pseudo-
aneurysm in patient 4.
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Fig 2, online only. A, Preoperative CT aortography of patient 9
reveals an aortoiliac typical saccular eccentric pseudoaneurysm
(arrowhead). B, Post-contrast MRI in patient 9 after Salmonella
septic aortic pseudoaneurysm excised one month postoperatively
demonstrates lumbar 3-5 osteomylelitis (arrowhead), and epidural
abscess (arrow).
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